![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Gish Gains FDA Clearance for Heparin-Coated Blood Reservoir
Gish Gains FDA Clearance for Heparin-Coated Blood Reservoir
March 28, 2005
CardioTech International announced that its wholly owned subsidiary, Gish Biomedical has received FDA clearance to sell a disposable soft shell venous reservoir that facilitates air removal during surgical procedures requiring extracorporeal support for up to six hours.
Gish received FDA clearance to market the Circulatory Technology V-BAG vacuum assisted soft shell venous reservoir with Gish's GBS heparin coating March 17. The company plans to offer the new heparin-coated application to customers immediately.
The use of vacuum assisted venous drainage is designed to minimize overall prime volume and surface area of the extracorporeal circuit during open-heart surgery.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct